Built-in data integrity is a bare minimum requirement in today’s BioPharmaceutical manufacturing. Good Manufacturing Practices (GMP) regulations of the Food and Drug Administration (FDA) highlight the ...
The University of Manchester's Centre of Excellence in Biopharmaceuticals (COEBP) has developed a biopharmaceutical manufacturing platform that allows rapid isolation of high-producing CHO cell ...
SAN JOSE, Calif.--(BUSINESS WIRE)--The biopharmaceutical contract manufacturing market will reach $6.3 billion this year, a 12% increase from prior year. As pharmaceutical and biotechnology companies ...
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company advancing a pipeline of innovative inflammation and immunology therapeutics, and the owner of Scinai Biopharma Services Ltd., ...
Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...
A bipartisan group of senators and representatives introduced legislation to establish a National Biopharmaceutical Manufacturing Center of Excellence (COE), inspired by recommendations from the ...
The MarketWatch News Department was not involved in the creation of this content. Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and ...
Sanofi is preparing a new vaccine and biopharmaceutical manufacturing facility in Singapore, located at Tuas Biomedical Park, Bloomberg reported Nov. 27. The plant, dubbed Modulus, represents an ...
The regulatory framework around biopharmaceutical manufacturing is exacting and continuously evolving. Companies must meet diverse global requirements while staying agile enough to deliver on ...
Why price, manufacturing and innovation are so intertwined for pharma. Europe’s pharmaceutical industry needs to m ...
As the demand for biologics accelerates, biopharma companies are under pressure to expand sterile manufacturing capacity ...
As the Formula 1 season kicks off in the APAC region, biopharma companies can take a page from the popular sport’s playbook around precision, adaptability, and the right team. In return, biopharma can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results